Apollo Endosurgery Inc logo

Apollo Endosurgery Inc

$ 5.12 -0.1 (-1.92%) 09:48 AM EST
P/E:
At Loss
P/B:
4.39
Market Cap:
$ 212.38M
Enterprise V:
$ 191.46M
Volume:
703.00
Avg Vol (2M):
136.22K
Also Trade In:
Volume:
703.00
Market Cap $:
212.38M
PE Ratio:
At Loss
Avg Vol (2-Month):
136.22K
Enterprise Value $:
191.46M
PB Ratio:
4.39
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.
Name Current Vs Industry Vs History
Cash-To-Debt 1.39
Equity-to-Asset 0.4
Debt-to-Equity 1.12
Debt-to-EBITDA -2.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.22
Distress
Grey
Safe
Beneish M-Score -2.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.98
9-Day RSI 38.3
14-Day RSI 39.68
6-1 Month Momentum % -12.59
12-1 Month Momentum % -38.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.37
Quick Ratio 5.47
Cash Ratio 4.56
Days Inventory 152
Days Sales Outstanding 58.84
Days Payable 69.95

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.8

Financials (Next Earnings Date:2022-11-01 Est.)

APEN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 68.491
EPS (TTM) ($) -0.97
Beta 2.83
Volatility % 75.3
14-Day RSI 39.68
14-Day ATR ($) 0.267906
20-Day SMA ($) 5.585
12-1 Month Momentum % -38.72
52-Week Range ($) 3.49 - 10.39
Shares Outstanding (Mil) 40.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Apollo Endosurgery Inc Filings

Document Form Filing Date
No Filing Data

Apollo Endosurgery Inc Analysis

Share your research

Headlines

See More
No news.